Paclitaxel (precursor) liposome
紫杉醇（前体）脂质体
Report date: 2022/11/24 15:37:50
Base Information
Drug NamePaclitaxel (precursor) liposome
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesJinling Pharmaceutical Co Ltd Technology CenterChina Pharmaceutical University
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Active IndicationsN/A
Inactive Indications